That is my understanding, on at least part of it, the part where MVTG is being paid cash for doing R&D in the MVTG lab with the 6 Ph.D.s working now in the MVTG lab. What else would the accountants call it? The inkind contributions of engineering work for the Pilot Plant is a question mark as to how the Auditors will account for it. Since it is a contribution to the construction of a pilot plant asset that MVTG will own for doing on the road demos, I would call it revenue and list it as part of the capital construction asset cost, then depreciate the asset once it is turned on, but I see so mucg screwy nonse in public accounting with the Sarbanes-Oxley accounting changes where a drop in stock price shows a gain in asset value as it eats away at a warrant value to show fake income, who knows what it will look like.
To me the three International issued patents MVTG has now should have a book value based on cost or market value listed in the financials, but the auditor is not putting any value on the MVTG patents that I suspect already have a real value of ten times the MVTG market cap.